Skip to main content
Clinical Trials/NCT00486707
NCT00486707
Completed
Not Applicable

Questionnaire for Ovarian Cancer Patients Regarding Acceptance and Willingness to Undergo Genetic Testing

M.D. Anderson Cancer Center1 site in 1 country237 target enrollmentJune 2007
ConditionsOvarian Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ovarian Cancer
Sponsor
M.D. Anderson Cancer Center
Enrollment
237
Locations
1
Primary Endpoint
Participants' Response to Survey Questions (Yes/No)
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.

Detailed Description

All eligible patients being seen in the Gynecology Center at the M.D. Anderson Cancer Center and at Gynecologic Oncology of Houston for follow-up or a new diagnosis of ovarian cancer will be asked to participate in this study by completing a questionnaire. This study will end when 400 completed questionnaires have been collected. We estimate that 40-60 ovarian cancer patients are seen in the Gynecology Center at the M.D. Anderson Cancer Center each week and that 20- 40 ovarian cancer patients are seen at Gynecologic Oncology of Houston each week. The completion of 400 questionnaires will provide adequate data to address our question in an expeditious time frame. The initial phase of this study is exploratory and does not involve a comparison group.

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
October 2008
Last Updated
13 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients must have the diagnosis of ovarian cancer.
  • Patients must be at least 18 years of age at the time of enrollment.
  • Patients must be able to read and write in the English language.

Exclusion Criteria

  • Patients that are unable to speak or write in the English language. Currently, the investigators' resources in genetic counseling are limited. In the future, they plan to expand the questionnaire and study to include additional languages.
  • Patients having previously undergone BRCA genetic testing.

Outcomes

Primary Outcomes

Participants' Response to Survey Questions (Yes/No)

Time Frame: 15-20 minutes to complete survey

Study Sites (1)

Loading locations...

Similar Trials